Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality
Digestive and Liver Disease · 2025-02 · 57 (2) · 549-557
DOI: 10.1016/j.dld.2024.10.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-02. Verfasst von Emma Vanderschueren und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Leuven, Herestraat 49, Leuven, Belgium; Department of Chronic Diseases, Metabolism…. Hauptthemen laut MEDLINE: Sarcopenia, Portasystemic Shunt, Transjugular Intrahepatic, Postoperative Complications. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: European Commission.
Abstract (Originalsprache)
BACKGROUND: Sarcopenia is an acknowledged risk factor for individuals with chronic liver disease, however, the influence on outcomes in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) remains underexplored. AIMS: This study aimed to investigate the association between sarcopenia and incidence of complications and mortality post-TIPS. METHODS: A retrospective analysis was performed on 175 patients who underwent TIPS between 2011-2021 at a Belgian tertiary care center. Transverse psoas muscle thickness (TPMT) was measured at baseline, with a subset of 85 patients having a second TPMT after 1-2 years for assessment of evolution. RESULTS: Over a median follow-up of 453 days (IQR 76-1179), sarcopenic patients exhibited a higher prevalence of complications (74.1% vs. 57.9%, p = 0.04) and one-year mortality (53.4% vs. 22.3%, p 10% from baseline TPMT/length post-TIPS, with the greatest improvement observed in severely sarcopenic patients (4.00 ± 4.55 mm/m vs. -0.82 ± 2.68 mm/m, p < 0.001) and in those patients free from TIPS-related complications (3.18 ± 4.09 mm/m vs. 1.31 ± 3.21 mm/m, p = 0.022). CONCLUSION: Sarcopenia increases the risk of complications and mortality post-TIPS. Importantly, sarcopenia improves in patients receiving TIPS, particularly in those with severe sarcopenia at baseline and free of TIPS-related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Hospital Leuven, Herestraat 49, Leuven, Belgium; Department of Chronic Diseases, Metabolism and Aging (CHROMETA), Catholic University of Leuven, Herestraat 49, L…
- Department of General Internal Medicine, Medical Intensive Care Unit, University Hospital Leuven, Herestraat 49, Leuven, Belgium.
- Department of Radiology, Abdominal Radiology, University Hospital Leuven, Herestraat 49, Leuven, Belgium.
- Department of Gastroenterology and Hepatology, University Hospital Leuven, Herestraat 49, Leuven, Belgium.
- Department of Radiology, Interventional Radiology, University Hospital Leuven, Herestraat 49, Leuven, Belgium.
Förderung
- European Commission
Zitieren
APA
Vanderschueren, E., Meersseman, P., Wilmer, A., Vandecaveye, V., Dubois, E., Van Eldere, A., Clerick, J., Peluso, J. P., Claus, E., Bonne, L., Verslype, C., Maleux, G., & Laleman, W. (2025). Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.10.013
Vancouver
Vanderschueren E, Meersseman P, Wilmer A, Vandecaveye V, Dubois E, Van Eldere A, et al. Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.10.013
BibTeX
@article{Vanderschueren2025,
author = {Vanderschueren, Emma and Meersseman, Philippe and Wilmer, Alexander and Vandecaveye, Vincent and Dubois, Evelyne and Van Eldere, Anne and Clerick, Jan and Peluso, Jo P and Claus, Eveline and Bonne, Lawrence and Verslype, Chris and Maleux, Geert and Laleman, Wim},
title = {Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.10.013}
}
EUVIMED